Dubai, February 15th
The UAE Rare Disease Society (UAERDS) has conducted a two days scientific discussions, gathering the experts from the UAE.
Genpharm was amongst the key industry supporters for this initiative.
The attendees covered several key topics including:
- Newborn screening and the outlook of inclusion of new diseases that have approved treatments.
- The Patient pathway and the challenges in diagnosis and follow up
- The most common rare diseases seen in the clinic and their management
For more info you can follow or contact the UAERDS on https://twitter.com/UAE_RDSociety